So far DTZ is tracking as expected following my departure after...

So far DTZ is tracking as expected following my departure after holding since IPO, although I was surprised at the retained SP strength considering a MC of over $100M without any decent revenue after many promises have been made. Next step, introduce a new CEO following share price weakness and issue all new senior management significant ST and LT performance hurdles set at a low bar or decent high bar. How that is done will be an indicator. After that, watch for approvals, anticipation of approvals, MOUs or firm contracts. Again, material indicators of anticipated performance (or not).Multiple pots on the stove, nothing finished to completion. I note, not a word of FDA approval anymore. Will continue to observe from the sidelines at this stage.
If I had time I would list all the ideas and promises to date since IPO (noting leadership changes over time), it would be a long diverse list. Be good if they focused on one definitive product and commercialised it. Yet to see that clear signal. Can anyone else?